Product Information
TIMOLOL MALEATE 0.25% EYE DROP is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.6435 per ML under NDC 64980051305. Its NADAC has been published 586 times since Jul 15, 2015.
FDA first approved this application on Apr 30, 2008. Its Orange Book therapeutic-equivalence code is AT1.
Strength
2.5 mg/mL
Manufacturer
Rising Pharma Holdings Inc.NDC
64980051305
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
TIMOLOL MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA077259FDA Approved
4/30/2008
TE Code
AT1
On Market Since
12/15/2014
Pharmacological Classes
Price Statistics
The NADAC for TIMOLOL MALEATE 0.25% EYE DROP has been published 586 times since Jul 15, 2015, and over the history we have for it it has risen 21.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6435 per ML |
|---|---|
| All-time high | $0.7797 (Jul 14, 2021) |
| All-time low | $0.4201 (Dec 19, 2018) |
| 52-week high | $0.6691 |
| 52-week low | $0.6137 |
| Median price | $0.6262 |
| Average price | $0.5988 |
| Largest weekly change | -24.7% (Nov 20, 2024) |
| Weeks tracked | 586 |
| Tracking since | Jul 15, 2015 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
timolol maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TIMOLOL MALEATE 0.25% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for TIMOLOL MALEATE 0.25% EYE DROP, manufactured by Rising Pharma Holdings Inc., is $0.6435 per ML (NDC 64980051305), effective Sep 30, 2026.
How has the price of TIMOLOL MALEATE 0.25% EYE DROP changed over time?
Over the history we have for it, the NADAC for TIMOLOL MALEATE 0.25% EYE DROP has risen 21.8%. It has been tracked across 586 weekly CMS publications since Jul 15, 2015.
What are the highest and lowest recorded NADAC prices for TIMOLOL MALEATE 0.25% EYE DROP?
Since Jul 15, 2015, the NADAC for TIMOLOL MALEATE 0.25% EYE DROP has ranged from a low of $0.4201 (Dec 19, 2018) to a high of $0.7797 (Jul 14, 2021), with a median of $0.6262 per ML.
Are there cheaper alternatives to TIMOLOL MALEATE 0.25% EYE DROP?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TIMOLOL MALEATE 0.25% EYE DROP, is $0.6002 per ML — about 7% below TIMOLOL MALEATE 0.25% EYE DROP.
Who manufactures TIMOLOL MALEATE 0.25% EYE DROP?
TIMOLOL MALEATE 0.25% EYE DROP (NDC 64980051305) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.